Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88,646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations.
Shen M, Chen S, Han X, Hao Y, Wang J, Li L, Chen T, Wang B, Zou L, Zhang T, Zhang W, Han X, Wang W, Yu H, Li K, Liu S, Jin A. Shen M, et al. Among authors: zhang w, zhang t. Cancer Immunol Immunother. 2024 Jun 4;73(8):150. doi: 10.1007/s00262-024-03729-y. Cancer Immunol Immunother. 2024. PMID: 38832948 Free PMC article.
Self-assembled nanoparticles based on DNA origami and a nitrated T helper cell epitope as a platform for the development of personalized cancer vaccines.
Kang Y, Zhang W, Yu Q, Gao L, Quan J, Gu F, Wu Y, Tian Y, Wu Z, Shao S, Zhou H, Duan S, Zhou Y, Zhang L, Gao X, Tian H, Yao W. Kang Y, et al. Among authors: zhang l, zhang w. Cancer Immunol Immunother. 2023 Aug;72(8):2741-2755. doi: 10.1007/s00262-023-03446-y. Epub 2023 Apr 29. Cancer Immunol Immunother. 2023. PMID: 37119260 Free PMC article.
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy.
Zhang W, Shi X, Huang S, Yu Q, Wu Z, Xie W, Li B, Xu Y, Gao Z, Li G, Qian Q, He T, Zheng J, Zhang T, Tong Y, Deng D, Gao X, Tian H, Yao W. Zhang W, et al. Among authors: zhang t. Cancer Immunol Immunother. 2024 Oct 3;73(12):245. doi: 10.1007/s00262-024-03830-2. Cancer Immunol Immunother. 2024. PMID: 39358493 Free PMC article.
Altered epitopes enhance macrophage-mediated anti-tumour immunity to low-immunogenic tumour mutations.
Yu Q, Zhang T, He T, Yang Y, Zhang W, Kang Y, Wu Z, Xie W, Zheng J, Qian Q, Li G, Zhang D, Mao Q, Gao Z, Wang X, Shi X, Huang S, Guo H, Zhang H, Chen L, Li X, Deng D, Zhang L, Tong Y, Yao W, Gao X, Tian H. Yu Q, et al. Among authors: zhang l, zhang w, zhang t, zhang d, zhang h. Immunology. 2024 Dec;173(4):654-671. doi: 10.1111/imm.13854. Epub 2024 Aug 22. Immunology. 2024. PMID: 39174487
Corrigendum to"PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responsesˮ [Canc. Lett. 476 (2020) 170-182].
Tian H, Kang Y, Song X, Xu Y, Chen H, Gong X, Zhang W, Xu Y, Xia X, Gao X, Yao W. Tian H, et al. Among authors: zhang w. Cancer Lett. 2021 Feb 28;499:4. doi: 10.1016/j.canlet.2020.05.016. Epub 2020 Jul 31. Cancer Lett. 2021. PMID: 32747014 No abstract available.
88,646 results
You have reached the last available page of results. Please see the User Guide for more information.